z-logo
open-access-imgOpen Access
Oral therapies in digestive oncology (Review)
Author(s) -
Caroline PrieuxKlotz,
Solène Dermine,
LolaJade Palmieri,
Julie Lavolé,
Stanislas Chaussade,
Catherine Brézault,
Romain Coriat
Publication year - 2020
Publication title -
oncology reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2020.7555
Subject(s) - medicine , cancer , medical prescription , chemotherapy , intensive care medicine , molecular medicine , oncology nursing , clinical oncology , digestive tract , oncology , pharmacology , nursing , cell cycle , nurse education
Targeted therapy and oral chemotherapy indications are increasing in the realm of digestive oncology. Oral intake of cancer agents is sometimes compulsory (no i.v. equivalent) or is preferred by the patient or the physician. Although oral chemotherapy facilitates the treatment of oncology patients, the treatment diversity, risk of pharmaceutical interactions and monitoring of side effects are potentially challenging and need to be fully acknowledged by the physician. We offer here a literature review of the indications, doses, side effects and monitoring of every oral therapy indicated in Digestive Oncology. We suggest a prescription algorithm including therapeutic education by the physician or a trained nurse, and pharmaceutical counseling.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom